OR WAIT null SECS
November 07, 2023
Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.
October 25, 2023
New company to be publicly listed as Citius Oncology, Inc.
October 24, 2023
Investment offers opportunity to expand global footprint, company says.
October 20, 2023
Sector is anticipated to grow at a CAGR of 9.3%.
October 17, 2023
The Vicenza site will run about 54,000 square feet in size.
Value is attributed to the rise in counterfeit cases and ongoing regulations surrounding anti-counterfeit packaging.
CDMO’s goal is to increase building’s aseptic manufacturing capacity.
October 12, 2023
Acquisition helps expand pharma marketing reach and opens door for growth opportunities.
October 10, 2023
The conference will focus on the full breadth of commercialization strategies and operations.
October 09, 2023
Acquisition includes company’s inflammatory disease medicines.